AstraZeneca says should know if vaccine works by year-end if trials resume
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
AstraZeneca says should know if vaccine works by year-end if trials resume

Coronavirus chronicle

Reuters
10 September, 2020, 03:10 pm
Last modified: 10 September, 2020, 04:25 pm

Related News

  • Cholera inoculation in Dhaka starting first week of May
  • Corruption allegation over vaccine has no evidence: Ahmad Kaikaus
  • 23 lakh citizens to get cholera vaccine in Dhaka from May
  • Meningitis vaccine protects against gonorrhoea: Studies
  • US court reinstates Biden federal employee Covid vaccine mandate

AstraZeneca says should know if vaccine works by year-end if trials resume

The CEO said AstraZeneca did not know the diagnosis for the volunteer in the trial, adding that it was not clear if they had transverse myelitis and more tests were needed

Reuters
10 September, 2020, 03:10 pm
Last modified: 10 September, 2020, 04:25 pm
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Photo:Reuters
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Photo:Reuters

AstraZeneca's chief executive Pascal Soriot said on Thursday that it should know before the end of the year whether its experimental vaccine would protect people from Covid-19, if the British drugmaker is allowed to resume trials which were paused this week.

It suspended the late-stage trials after an illness in a study subject in Britain. The patient was reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.

Soriot said during a call on the vaccine, which the World Health Organization (WHO) has flagged as the most promising in combatting coronavirus, that it was very common for a trial to be suspended, the difference being that the world was watching.

Oxford Covid-19 vaccine may resume trials next week

The CEO said AstraZeneca did not know the diagnosis for the volunteer in the trial, adding that it was not clear if they had transverse myelitis and more tests were needed.

Soriot said the diagnosis would be submitted to an independent safety committee and this would usually then tell the company whether trials can be resumed.

Top News

AstraZeneca / Vaccine / Trial

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Students suffer over costlier food at public university canteens
    Students suffer over costlier food at public university canteens
  • A worker displays grains of wheat at a mill in Beirut, Lebanon, March 1, 2022. REUTERS/Mohamed Azakir/File Photo
    Russia can offer 25 mln tonnes of grain for export starting on 1 Aug: UN envoy
  • A model of the natural gas pipeline is seen in front of displayed Finnish and Russian flag colours in this illustration taken April 26, 2022. REUTERS/Dado Ruvic/Illustration
    Russian gas flows to Finland to stop on Saturday, says Gasum

MOST VIEWED

  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop

Related News

  • Cholera inoculation in Dhaka starting first week of May
  • Corruption allegation over vaccine has no evidence: Ahmad Kaikaus
  • 23 lakh citizens to get cholera vaccine in Dhaka from May
  • Meningitis vaccine protects against gonorrhoea: Studies
  • US court reinstates Biden federal employee Covid vaccine mandate

Features

Mohammad (Mejbah) Mejbahuddin, Former Senior Secretary, Economic Relations Division (ERD), Ministry of Finance, Government of Bangladesh. TBS Sketch

‘No project is being delayed too long at the moment’

53m | Panorama
Dr Shamsul Hoque, Professor, Civil Engineering, BUET. TBS Sketch

‘Planning commission only in the name, there are no planners’ 

58m | Panorama
Masrur Reaz. TBS Sketch

‘To ensure accountability, contract financing should be based on ‘performance based payments’

1h | Panorama
Professor Mustafizur Rahman. Illustration: TBS

Project delays and escalating costs are driven by frequent revisions and lack of good governance

4h | Panorama

More Videos from TBS

Ways to retain body fragrance

Ways to retain body fragrance

2h | Videos
Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

5h | Videos
How to prepare for a job

How to prepare for a job

6h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

18h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab